Journey Medical Corporation (NASDAQ: DERM)
$6.05
+0.1400 ( +2.37% ) 28.5K
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Market Data
Open
$6.05
Previous close
$5.91
Volume
28.5K
Market cap
$119.08M
Day range
$5.86 - $6.10
52 week range
$1.60 - $8.11
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 12, 2024 |
4 | Insider transactions | 1 | Jul 10, 2024 |
4 | Insider transactions | 1 | Jul 10, 2024 |
4 | Insider transactions | 1 | Jul 10, 2024 |
4 | Insider transactions | 1 | Jul 10, 2024 |
8-k | 8K-related | 14 | Jun 25, 2024 |
3 | Insider transactions | 1 | May 31, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
10-q | Quarterly Reports | 85 | May 14, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |